Experimental group:Qidongbufei decoction
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
Conditions
non-small cell lung cancer
Early Phase 1
The efficacy of Qidongbufei Decoction in treating NSCLC postoperative symptoms: a randomized, double-blind, placebo-controlled pilot study
RecruitingChiCTR2000038612
Start: 2020-09-21Updated: 2021-05-17
The efficacy of Qidongbufei Decoction in treating NSCLC postoperative symptoms: a randomized, double-blind, placebo-controlled pilot study
RecruitingITMCTR2000003983
Start: 2020-09-21Updated: 2023-02-20
A randomized, double-blind, placebo-controlled trial of Qidong Bufei Decoction in treating postoperative symptoms of non-small cell lung cancer
RecruitingITMCTR2100004896
Start: 2021-05-28Updated: 2023-02-20
A randomized, double-blind, placebo-controlled trial of Qidong Bufei Decoction in treating postoperative symptoms of non-small cell lung cancer
RecruitingChiCTR2100046765
Start: 2021-05-28Updated: 2022-01-10